[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"compliance-patient\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:compliance-patient":28},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,3,0,[8,50,76],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":4,"eligibilityCriteria":15,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":4,"enrollmentInfo":18,"targetDuration":4,"studyType":21,"phases":22,"briefSummary":24,"conditions":25,"keywords":31,"overallStatus":37,"whyStopped":4,"lastUpdateSubmitDate":38,"lastUpdatePostDateStruct":39,"startDateStruct":42,"completionDateStruct":44,"leadSponsor":46,"locationsCount":49},"100451331","phase-4-evaluating-a-dropless-postoperative-regimen-after-cataract-surgery-in-a-vulnerable-county-hospital-population-100451331",false,"NCT05157113","Evaluating a Dropless Postoperative Regimen After Cataract Surgery in a Vulnerable, County-hospital Population","Evaluating the Efficacy, Compliance, and Patient Satisfaction of a New Dropless Postoperative Regimen After Cataract Surgery in a Vulnerable, County-hospital Population","Inclusion criteria:\n\n* ZSFG patient initially seen in the eye clinic, approved by attending ophthalmologist for cataract surgery in both eyes due to visually significant cataracts, and who elects to have cataract surgery in both eyes.\n* Patients 18 years of age or older\n\nExclusion criteria:\n\n* Patients requiring bilateral simultaneous (same-day bilateral) cataract surgery\n* Patients with prior history of: endophthalmitis, advanced glaucoma, known history of intraocular pressure elevation due to steroids, prior intraocular surgery, cystoid macular edema\u002Fdiabetic macular edema\u002Fretinal edema noted in the past 12 months prior to cataract surgery\n* Patients with documented penicillin or cephalosporin allergy or intolerance\n* Patients requiring combined same day cataract and ophthalmic subspecialty procedure (eg; combined cataract and glaucoma, retina, or cornea surgery).\n* Patients who are pregnant or breastfeeding","ALL","18 Years",{"count":19,"type":20},70,"ESTIMATED","INTERVENTIONAL",[23],"PHASE4","The current postoperative cataract surgery eye drop regimen used at Zuckerberg San Francisco General Hospital (ZSFG) is a significant burden for its patient population, contributing to high rates of non-adherence and the development of postoperative complications. The investigators propose to replace this complex regimen with a single administration of intraocular antibiotic and subconjunctival steroid at the time of surgery. This pilot study will obtain the preliminary data required to eventually fully evaluate this innovation in postoperative care in a safety-net population with respect to postoperative outcomes, patient compliance, and patient and caregiver satisfaction.",[26,27,28,29,30],"Cataract","Surgery","Compliance, Patient","Compliance, Medication","Satisfaction, Patient",[32,33,34,35,36],"cataract surgery","post-operative care","vulnerable populations","compliance","patient satisfaction","RECRUITING","2025-07-18",{"date":40,"type":41},"2025-07-23","ACTUAL",{"date":43,"type":41},"2022-05-31",{"date":45,"type":20},"2026-06-01",{"name":47,"class":48},"University of California, San Francisco","OTHER",1,{"id":51,"slug":52,"hasResults":11,"nctId":53,"briefTitle":54,"officialTitle":55,"acronym":4,"eligibilityCriteria":56,"healthyVolunteers":57,"sex":16,"minAge":4,"maxAge":4,"enrollmentInfo":58,"targetDuration":4,"studyType":60,"phases":4,"briefSummary":61,"conditions":62,"keywords":4,"overallStatus":37,"whyStopped":4,"lastUpdateSubmitDate":67,"lastUpdatePostDateStruct":68,"startDateStruct":70,"completionDateStruct":72,"leadSponsor":74,"locationsCount":49},"100496836","vaccinations-and-people-with-disabilities-100496836","NCT05749419","Vaccinations and People With Disabilities","Questionnaires and Focus Groups Based Quantitative & Qualitative Study of Vaccine Hesitancy and Confidence Among At-risk and Marginalized Populations: Persons With Special Needs, Intellectual Disabilities and Congenital Anomalies","Inclusion Criteria:\n\n• Diagnosed children with disabilities, chronic diseases or congenital anomalies\n\nExclusion Criteria:\n\n* Undiagnosed children\n* Inadequate filled out questionnaires",true,{"count":59,"type":20},1000,"OBSERVATIONAL","The goal of this observational study is to learn about vaccinations hesitancy, delay or avoidance in children with chronic diseases, congenital anomalies or disabilities. The main questions it aims to answer are:\n\n• Attitudes of caregivers towards vaccinating their children, obstacles that postpone vaccinations, and the status of vaccinations of these children.\n\nParticipants will fill out questionnaires and some will be included in focused groups for the qualitative part of the study.\n\nResearchers will compare the vaccinations status of the research group to their siblings' status as well as the published national records of vaccination compliance.",[63,28,64,65,66],"Vaccine Refusal","Disability, Intellectual","Congenital Disorders","Pediatric Disorder","2025-04-01",{"date":69,"type":41},"2025-04-03",{"date":71,"type":41},"2023-07-01",{"date":73,"type":20},"2026-01",{"name":75,"class":48},"Hadassah Medical Organization",{"id":77,"slug":78,"hasResults":11,"nctId":79,"briefTitle":80,"officialTitle":80,"acronym":81,"eligibilityCriteria":82,"healthyVolunteers":57,"sex":16,"minAge":17,"maxAge":4,"enrollmentInfo":83,"targetDuration":4,"studyType":21,"phases":85,"briefSummary":87,"conditions":88,"keywords":91,"overallStatus":93,"whyStopped":4,"lastUpdateSubmitDate":94,"lastUpdatePostDateStruct":95,"startDateStruct":97,"completionDateStruct":99,"leadSponsor":101,"locationsCount":4},"100517401","coaching-for-coping-in-glioblastoma-patients-and-caregivers-and-its-association-with-compliance-to-ttfields-100517401","NCT06017063","Coaching for Coping in Glioblastoma Patients and Caregivers and Its Association With Compliance to TTFields","COCOON","Inclusion Criteria:\n\n* Ability to understand and give an informed consent, capacity to consent\n* Given informed consent\n* ≥ 18 years of age\n* Patients with newly diagnosed glioblastoma\n* Patients with IDH-mutant Astrocytoma, CNS WHO-Grade 4, newly diagnosed (by biopsy or incomplete tumor resection)\n* Patients eligible for radiochemotherapy with temozolomide and 60 Gy\n* Patients before radiochemotherapy phase or within the first 2 weeks\n* Prescription of TTFields according clinical routine (including but not exclusive to)\n* Access to a computer and internet\n* Absence of medical reasons precluding participation in a supportive intervention\n\nExclusion Criteria:\n\n* Ability to understand and give an informed consent, capacity to consent\n* Given informed consent\n* ≥ 18 years of age\n* Being a family caregiver of a patient with newly diagnosed glioblastoma\n* Access to a computer and internet\n* Absence of medical reasons precluding participation in a supportive intervention",{"count":84,"type":20},275,[86],"NA","The aim is to improve patients' compliance to TTFields therapy by a psychological video intervention in a multi-center, randomized controlled trial.",[28,89,90],"Glioblastoma","Astrocytoma, Grade IV",[92],"psychosocial support","NOT_YET_RECRUITING","2023-08-23",{"date":96,"type":41},"2023-08-30",{"date":98,"type":20},"2023-10",{"date":100,"type":20},"2026-09",{"name":102,"class":48},"University Hospital Tuebingen"]